Drug intelligence / Profile preview

ketogenic medium-chain triglycerides

Development stage
Unknown
Administration
Oral
01

Overview

**Ketogenic medium-chain triglycerides** are specialized dietary formulations or supplements consisting primarily of medium-chain triglycerides (MCTs), often from sources such as caprylic acid (C8) and capric acid (C10), used to rapidly induce and maintain ketosis for therapeutic purposes. Their key mechanism is the ability to bypass regular fat absorption pathways, being directly transported via the portal vein to the liver, where they convert quickly into ketone bodies. This property enables the body to generate ketones efficiently without the need for strict carbohydrate restriction or fasting. Ketogenic MCTs are mainly used as part of dietary therapies for drug-resistant epilepsy, especially in children, and are being researched for neurodegenerative diseases like Alzheimer's. Compared to traditional ketogenic diets, MCT-based ketogenic regimens allow a higher intake of carbohydrates and protein, improving palatability and adherence, while lowering the risk of certain side effects like hypoglycemia and constipation[1][2][3][4][5].

Brand names
Captex 1000Captex1000Captex-1000Captex 8000Captex8000Captex-8000
Other names
MCT ketogenic formulationMCT oil ketogenic preparationmedium-chain triglyceride ketogenic dietMCTKD
02

Targets

AMPAR (AMPA receptor)

Beyond the preview

Go deeper on ketogenic medium-chain triglycerides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketogenic medium-chain triglycerides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call